A multi-stakeholder panel discussion featuring insight on the use of prescription digital therapeutics as tools when managing behavior-driven conditions.
EP. 1: Prescription Digital Therapeutics in Behavior-Driven Conditions EP2January 6th 2021
Clinicians, a pharmacist, and a payer discuss their current experience with prescription digital therapeutics for behavior-driven conditions and share considerations for expanding on their use in clinical practice.
EP. 4: Prescription Digital Therapeutics: Clinical OutcomesJanuary 6th 2021
Current experiences noted by various stakeholders in healthcare regarding the impact of prescription digital therapeutics in clinical practice as tools to help manage patients with behavior-driven conditions, and current limitations that need to be addressed to increase their uptake.
EP. 6: Prescription Digital Therapeutics: Coverage and ReimbursementJanuary 6th 2021
Steven Peskin, MD, MBA, FACP, shares perspective on factors that need to be considered by payers when making decisions about how to cover and reimburse for prescription digital therapeutics used to manage behavior-driven conditions.